Latest Novartis AG Stories
RnRMarketResearch.com adds "Acute Heart Failure - Pipeline Review, H1 2015" report to its store.
-- In Quebec alone 386,000 people suffer from COPD and it is the fourth leading cause of death in Canada.
With today's approval, Bexsero is now licensed in 37 countries; since first approval in Europe, over 1 million doses have been distributed worldwide BASEL, Switzerland, Jan.
ReportsnReports.com adds Hepatitis B Global Clinical Trials Review H2 2014 to its store.
ReportsnReports.com adds Hepatitis C Global Clinical Trials Review H2 2014 to its store.
AUSTIN, Texas, Nov. 4, 2014 /PRNewswire/ -- XBiotech announced today that Dr. Daniel Vasella has joined the Company as a member of the Board of Directors. Dr.
-- LANTERN study met primary endpoint demonstrating non-inferiority of Ultibro® Breezhaler® 110/50 mcg vs Advair* Diskus* (SFC) 50/500 mcg followed by statistically
-- LCZ696 mortality benefit exceeded what was achieved with enalapril, an ACE-inhibitor, when replacing enalapril combined with current treatment
- The act of burning, scorching, or heating to dryness; the state or being thus heated or dried.
- In medicine, cauterization.